BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17011461)

  • 1. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
    O'Daniel JC; Dong L; Zhang L; de Crevoisier R; Wang H; Lee AK; Cheung R; Tucker SL; Kudchadker RJ; Bonnen MD; Cox JD; Mohan R; Kuban DA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):883-91. PubMed ID: 17011461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.
    O'Daniel JC; Dong L; Zhang L; Wang H; Tucker SL; Kudchadker RJ; Lee AK; Cheung R; Cox JD; Kuban DA; Mohan R
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):274-80. PubMed ID: 18406891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
    Mutanga TF; de Boer HC; van der Wielen GJ; Hoogeman MS; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1160-7. PubMed ID: 21035957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
    Yoo S; Wu QJ; Lee WR; Yin FF
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
    Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy.
    Peng C; Ahunbay E; Chen G; Anderson S; Lawton C; Li XA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):909-14. PubMed ID: 20732764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.
    Zhang X; Dong L; Lee AK; Cox JD; Kuban DA; Zhu RX; Wang X; Li Y; Newhauser WD; Gillin M; Mohan R
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):620-9. PubMed ID: 17236979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
    Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
    Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization.
    Schulze D; Liang J; Yan D; Zhang T
    Radiother Oncol; 2009 Mar; 90(3):367-76. PubMed ID: 18976828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online adaptive replanning method for prostate radiotherapy.
    Ahunbay EE; Peng C; Holmes S; Godley A; Lawton C; Li XA
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1561-72. PubMed ID: 20362401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer.
    Liang J; Wu Q; Yan D
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):935-43. PubMed ID: 19111401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single course IMRT plan to deliver 45 Gy to seminal vesicles and 81 Gy to prostate in 45 fractions.
    Reddy NM; Sood BM; Sampath S; Mazur A; Osian A; Ravi A; Poli J; Nori D
    Technol Cancer Res Treat; 2006 Oct; 5(5):503-11. PubMed ID: 16981793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy.
    Pawlowski JM; Yang ES; Malcolm AW; Coffey CW; Ding GX
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):924-34. PubMed ID: 20004528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.